HumanIG (Human Normal Immunoglobulin IP 5%)

Get a Price/Quote

MOQ : 10 Vials

HumanIG (Human Normal Immunoglobulin IP 5%) Specification

Brand Name
HumanIG

Salt Composition
Immunoglobulin (Human) 5%

Origin of Medicine
India

Life Span
Refer to packaging for expiry date

Dosage Form
Injection

Indication
Primary immunodeficiency, secondary immunodeficiency, immunomodulatory therapy

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Biological

Ingredients
Human Normal Immunoglobulin IP 5%

Physical Form
Liquid

Function
Provides immune protection by supplying immunoglobulin G (IgG) antibodies

Recommended For
Treatment of immunodeficiency disorders

Dosage
As prescribed by physician

Dosage Guidelines
Administered intravenously under medical supervision

Suitable For
Adults and children (as per physicians advice)

Quantity
5 g

Storage Instructions
Store below 25C. Do not freeze. Protect from light.

Patient Population
Intended for clinically justified patients under specialist supervision

Route of Administration
Intravenous

Precautions
Monitor for allergic reactions and infusion-related side effects

Regulatory Approval
Approved as per Indian Pharmacopoeia standards

Prescription/Non prescription
Prescription

Container Type
Glass vial

Colour
Clear to slightly opalescent

Therapeutic Class
Immunoglobulin Replacement Therapy

Strength
5% (50 mg/mL)

HumanIG (Human Normal Immunoglobulin IP 5%) Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About HumanIG (Human Normal Immunoglobulin IP 5%)

HumanIG (Human Normal Immunoglobulin IP 5%) is a venerable solution designed for the treatment of immunodeficiency disorders, offering meritorious immune protection through 5% IgG antibodies. This reduced-formulation biological acts as a vital resource for those requiring immunoglobulin replacement, ensuring instant checkout for urgent orders. Intended for clinically justified patients under specialist supervision, HumanIG is administered intravenously for unprecedented efficacy. Approved as per Indian Pharmacopoeia standards, it comes in a clear to slightly opalescent liquid housed in glass vials, ensuring both purity and stability. Premium preservation and supply adhere to stringent quality and storage requirements.

Applications and Versatility of HumanIG 5%

Used as a cornerstone in immunoglobulin replacement therapy, HumanIG 5% treats primary and secondary immunodeficiency and serves broad immunomodulatory purposes. Beyond replacement, its premium formulation is an effective adjunct in specialized therapies where strengthening the immune response is crucial. Application is accomplished via intravenous administration, making it appropriate for both adult and pediatric patients when prescribed. This solution finds merit on the surface of clinical practice, supporting vulnerable patients across varied medical settings.

Distribution, Quotation, and Market Coverage

HumanIG 5% is available through handover at all major Indian FOB ports, ensuring efficient distribution across the premium domestic market. Suppliers, traders, and wholesalers in India may request a tailored quotation based on supply ability and market requirements. Our logistics expertise guarantees prompt order processing, delivering HumanIG securely and swiftly to healthcare providers nationwide. This robust supply chain upholds the product's quality, meeting both urgent and scheduled needs in the healthcare market.

FAQ's of HumanIG (Human Normal Immunoglobulin IP 5%):

Q: How should HumanIG (Human Normal Immunoglobulin IP 5%) be administered?

A: HumanIG must be administered intravenously under specialist medical supervision. Follow the dosage and guidelines prescribed by your physician for optimal safety and effectiveness.

Q: What are the main benefits of using HumanIG for patients with immunodeficiency?

A: HumanIG offers meritorious immune protection by supplying vital IgG antibodies, helping to reduce infection risk and stabilize immune function in both primary and secondary immunodeficiency cases.

Q: When should I consider using HumanIG in a treatment plan?

A: HumanIG is indicated for patients diagnosed with primary or secondary immunodeficiency, or when immunomodulatory therapy is merited. Always consult your specialist for clinical justification before initiating treatment.

Q: Where can I obtain further information or a quotation for HumanIG 5%?

A: Suppliers, traders, and wholesalers in India can request a quotation through official distribution channels. Availability and handover typically occur at major domestic ports.

Q: What precautions should be taken during and after HumanIG infusion?

A: Monitor patients closely for allergic reactions and infusion-related side effects during and after administration. Ensure storage below 25C, away from light, and do not freeze the product.

Tell us about your requirement